BAT8001
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BAT8001, covering 2019-11-05 to 2019-12-04. Get the full timeline:
Most recent: Clinical Trial Update: The Efficacy and Safety of BAT8001 Injection for the Treatment of HER2-positive Advanced Breast Cancer [Phase 3]